Manley West

West-Med Limited is a Jamaican pharmaceutical company founded by the late Dr. Manley West and Dr. Albert Lockhart to commercialize their pioneering research into cannabinoid-based therapeutics. The company is globally recognized for developing Canasol, one of the first cannabis-derived pharmaceutical products for the treatment of glaucoma, which was launched in 1987. In addition to ophthalmic care, West-Med produces Asmasol, a cannabinoid-based treatment for asthma and other respiratory conditions. The company's business model focuses on the extraction and formulation of natural compounds from indigenous Caribbean flora to address chronic health conditions. West-Med remains a key player in the regional pharmaceutical industry, maintaining a legacy of innovation in natural product pharmacology.